BioAge Labs, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+2.64%
vs ±59.0% implied · ×0.04
shaded = implied · ▲▼ = realized
Fund move
Fund move
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | AH Capital ManagementAH Capital Management | $79.2M | 8.35% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $69.8M | 7.36% | +25.63% | |
| 3 | Cormorant Asset ManagementCormorant | $58.6M | 6.17% | −17.30% | |
| 4 | Sofinnova InvestmentsSofinnova | $56.2M | 5.92% | 0.00% | |
| 5 | Jupiter TopcoJupiter Topco | $52.6M | 5.54% | — | |
| 6 | Octagon Capital AdvisorsOctagon Capital | $42.8M | 4.51% | 0.00% | |
| 7 | RA Capital ManagementRA Capital Management | $41.0M | 4.32% | +1.27% | |
| 8 | MPM Oncology Impact ManagementMPM Oncology Impact | $40.9M | 4.31% | new | |
| 9 | Vanguard Capital ManagementVanguardindex-like | $37.8M | 3.99% | +13.97% | |
| 10 | Polar Capital HoldingsPolar Capital | $26.3M | 2.77% | −5.32% | |
| 11 | BraidwellBraidwell | $25.3M | 2.67% | −13.95% | |
| 12 | State StreetState Streetindex-like | $25.0M | 2.64% | +20.05% | |
| 13 | Geode Capital ManagementGeodeindex-like | $24.6M | 2.59% | +34.03% | |
| 14 | Sands Capital VenturesSands Capital Ventures | $19.3M | 2.03% | 0.00% | |
| 15 | Orbimed AdvisorsOrbimed | $18.4M | 1.94% | +5.67% | |
| 16 | D. E. ShawD. E. Shaw | $18.2M | 1.92% | +6.23% | |
| 17 | Balyasny Asset ManagementBalyasny | $17.2M | 1.81% | −47.06% | |
| 18 | Pivotal bioVenture Partners Investment AdvisorPivotal bioVenture Partners Investment Advisor | $16.0M | 1.69% | 0.00% | |
| 19 | Cosmic ManagementCosmic | $12.3M | 1.30% | 0.00% | |
| 20 | StemPoint CapitalStemPoint Capital | $11.4M | 1.20% | +37.06% | |
| 21 | Susquehanna International GroupSusquehanna International | $10.1M | 1.07% | +199.68% | |
| 22 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $10.1M | 1.06% | +42.94% | |
| 23 | Squadron Capital ManagementSquadron | $9.9M | 1.05% | new | |
| 24 | Dimensional Fund AdvisorsDimensional | $9.7M | 1.02% | +83.71% | |
| 25 | Jacobs Levy Equity ManagementJacobs Levy Equity | $9.2M | 0.97% | −10.24% |
149 managers report $949.4M of BioAge Labs on form 13F for the quarter ended Jun 30 '26. 28 of them hold 80% of it; AH Capital Management is largest at 8.35%.
BioAge Labs, Inc.
5.87
No implied move.
No implied move.
Expected move
No implied move.